Clinical Trial Update: Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of Viokase 16 for correcting steatorrhea in exocrine pancreatic insufficiency and chronic pancreatitis; the trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency
• Pancreatitis

Drugs mentioned

• Viokase 16 (pancrelipase)

Snippet

Sponsor: Forest Laboratories | Conditions: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-12